It’s rare to find a small biotech stock that’s likely standing on the edge of a medical breakthrough – but Stoke Therapeutics (Nasdaq: STOK) is one of them.
Stoke’s mission is simple but bold: Use RNA science to “fix” diseases caused by missing or insufficient proteins.
The company’s approach works by… Keep Reading
This post appeared first on Trades Of The Day.